Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Coloboma of choroid and retina is a rare, genetic developmental defect during embryogenesis characterized by the partial absence of retinal pigment epithelium and choroid, most frequently located in the inferonasal quadrant. Patients usually present reduced vision and have an increased risk for retinal detachment. Other ocular anomalies (e.g. coloboma of iris, microcornea, nystagmus, strabismus, microphthalmos) are usually associated, however it may also be isolated.
Biomarker and diagnostic research for coloboma of choroid and retina has been reported in the published literature.
No clinical trials have been registered for coloboma of choroid and retina.
34 publications have been identified in PubMed for coloboma of choroid and retina. Kisho has analyzed 26 by research type. Research spans Case Report / Case Series (58%), Review / Meta-Analysis (23%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 58% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 8:13 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about coloboma of choroid and retina
Research summaries
6 |
23% |
Testing and diagnosis research | 2 | 8% |
Laboratory research | 2 | 8% |
Disease patterns and progression | 1 | 4% |
Ivanišević M (2026). [PMID: 41984390](https://pubmed.ncbi.nlm.nih.gov/41984390/). *Wien Med Wochenschr*. [Review / Meta-Analysis]
Patterson KN (2026). [PMID: 41503034](https://pubmed.ncbi.nlm.nih.gov/41503034/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Yang LY (2026). [PMID: 41110675](https://pubmed.ncbi.nlm.nih.gov/41110675/). *Am J Ophthalmol*. [Diagnostic / Biomarker]
Bidasaria A (2026). [PMID: 40009871](https://pubmed.ncbi.nlm.nih.gov/40009871/). *Retin Cases Brief Rep*. [Case Report / Case Series]
Azzam D (2026). [PMID: 32119320](https://pubmed.ncbi.nlm.nih.gov/32119320/). *Unknown Journal*. [Basic Science / Preclinical]
Liang J (2025). [PMID: 41551514](https://pubmed.ncbi.nlm.nih.gov/41551514/). *Front Med (Lausanne)*. [Case Report / Case Series]
Diaz A (2025). [PMID: 40736823](https://pubmed.ncbi.nlm.nih.gov/40736823/). *Adv Exp Med Biol*. [Review / Meta-Analysis]
Faes L (2025). [PMID: 39503663](https://pubmed.ncbi.nlm.nih.gov/39503663/). *Ophthalmology*. [Case Report / Case Series]
Palanivel S (2025). [PMID: 41148017](https://pubmed.ncbi.nlm.nih.gov/41148017/). *Indian J Ophthalmol*. [Case Report / Case Series]
Le T (2025). [PMID: 40114969](https://pubmed.ncbi.nlm.nih.gov/40114969/). *Front Cell Dev Biol*. [Case Report / Case Series]